New Delhi, Aug. 6 -- Diagnostics major Metropolis Healthcare is accelerating its expansion into India's tier-II and tier-III markets, capitalizing on a multi-year investment push designed to capture a... Read More
Mumbai, Aug. 1 -- Sun Pharmaceutical Industries, India's biggest drugmaker by market capitalization, missed Street expectations in the June quarter as weakness in its US generics business weighed on p... Read More
New Delhi, July 31 -- Sun Pharmaceutical Industries, India's largest drugmaker market capitalization, missed Street expectations in the June quarter as weakness in its US generics business weighed on ... Read More
New Delhi, July 30 -- India's domestic pharmaceutical market is emerging as a bright spot for drugmakers, helping companies with a strong local franchise outpace peers exposed to the increasingly chal... Read More
New Delhi, July 26 -- Last week, US President Donald Trump announced a phased tariff plan for low-cost generic drugs, with the aim of bringing manufacturing back to the US. While many believe the plan... Read More
New Delhi, July 23 -- Cipla, which posted its financial results for the June quarter on Thursday, saw its profits dip 39% over softer US sales. However, the company expects sequential sales momentum i... Read More
New Delhi, July 22 -- US President Donald Trump has announced a phased tariff plan on imported generic medicines that will escalate duties to 200% by 2029 if foreign manufacturers-led by India's multi... Read More
New Delhi, July 21 -- The Indian pharmaceutical sector is expected to post healthy revenue growth in the April-June quarter (Q1FY27), supported by domestic demand and acquisitions, but the US business... Read More
Mumbai, July 20 -- Quick medicine delivery platform Plazza has raised $15 million in a Series A funding round co-led by Accel, Elevation Capital, and Nexus Venture Partners, with participation from ex... Read More
New Delhi, July 15 -- Venture capital (VC) firm HealthKois is sharpening its focus on life sciences innovation as it evaluates investment opportunities for its $300-million third fund, amid a growing ... Read More